Literature DB >> 23360241

Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease.

Rashmi Sareen1, Nitin Jain, K L Dhar.   

Abstract

In the present investigation chitosan microspheres loaded with flurbiprofen (FLB) were prepared by oil/oil emulsification method for colon specific drug delivery. FLB was entrapped in chitosan microspheres, following coating with Eudragit S-100 utilizing the benefits of pH dependent solubility of Eudragit S-100, so as to prevent the premature release of FLB in upper GIT. Different batches of FLB microspheres were prepared by varying FLB: chitosan ratio (1:1 to 1:4). The effect of chitosan concentration on size, entrapment efficiency, percent drug loading and degree of swelling was evaluated. DSC studies revealed the dispersion of FLB in the matrix of chitosan microspheres. SEM analysis indicated the nearly smooth surface and spherical shape of the prepared microspheres. X-ray diffract gram of FLB microspheres showed less intense peaks as compared to free FLB. In vitro release studies of uncoated FLB- chitosan microspheres showed burst release in initial 4 h, while Eudragit S-100 coated microspheres prevented the premature release of FLB and showed controlled release for 12 h following Higuchi model, thus suitable for colon specific drug delivery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360241     DOI: 10.2174/1567201811310050008

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  2 in total

1.  Development and optimization of osmotically controlled asymmetric membrane capsules for delivery of solid dispersion of lycopene.

Authors:  Nitin Jain; Rashmi Sareen; Neeraj Mahindroo; K L Dhar
Journal:  ScientificWorldJournal       Date:  2014-01-29

2.  Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation.

Authors:  Rashmi Sareen; Kavita Nath; Nitin Jain; K L Dhar
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.